Empowering you to deliver high standard of care in your interventional oncology procedures
Visit us at ECIO 2021 – 10-13 April 2021
Join our symposium
Ablation procedures in the interventional oncology suite of today and tomorrow
April 13th 18:00-18:30 CET
Moderator:
Faiza Admiraal-Behloul, PhD, Philips
Liver ablation procedures in the Angio lab: the pros and cons
Interventional Oncology Procedures in the angio lab of today and in the future
Prof. Gianpaolo Carrafiello, interventional radiologist
Università degli Studi di Milano, Ospedale Maggiore Policlinico Milano, Italy
Dr Marco van Strijen, interventional Radiologist
St. Antonius Hospital Nieuwegein, the Netherlands
The next leap in simplifying and advancing 3D imaging
The SmartCT clinical application, part of the Azurion image guided therapy platform, enriches our outstanding 3D interventional tools with clear guidance, designed to remove barriers to acquiring 3D images in the interventional lab.
It simplifies 3D acquisition to empower clinical users to easily perform 3D imaging, regardless of their experience. Once acquired, 3D images are automatically displayed within seconds on the touch screen module in the corresponding rendering mode. On the same touch screen, the user can easily control and interact with advanced 3D visualization and measurement tools.
Image fusion and needle navigation
Enhance your performance in challenging interventions
Make confident decisions even in challenging diagnostic cases with Philips image fusion and needle navigation capabilities. Streamlined workflow allows clinicians to achieve fast and effective fusion of CT/CBCT/MR/PET with live ultrasound while needle navigation aids in guiding biopsy of small and difficult-to-access lesions.
Pre-procedural
CT Liver and 3D Modeling in IntelliSpace Portal
Access advanced visualization software from anywhere across the Enterprise to design the treatment strategy, using advanced tools such as automated organ and tumor segmentation and quantification, volumetric multimodal fusion and tumor characterization.
Use pre-procedural CT and MR images to create a fused multimodal volumetric model of the liver*
* Not intended for diagnostic use
Ablation procedures with XperGuide Ablation*
XperGuide Ablation provides comprehensive assistance for treatment planning and live needle guidance. It offers unique Parallax Correction to plan needle trajectories for off-center lesions [3]. It provides highly accurate live image guidance of each needle to a targeted position by overlaying pre-planned trajectories with fluoroscopic imaging [4]
* XperGuide Ablation is an option of XperGuide
TACE procedures with EmboGuide
EmboGuide supports you in maximizing the efficacy of your TACE procedures as it potentially enhances your sensitivity, reduces false positives and maximizes inter-reader agreement [1]. It provides efficient, workflow-based live 3D guidance with automatic feeder detection [2].
Post-procedural
Multimodality Tumor Tracking in IntelliSpace Portal
Compare pre- and post-procedural images to assess early treatment response, and use selected imaging biomarkers from multiple modalities to follow-up the patient over time. qEASL is particularly useful to evaluate changes in tumor volume and enhancement. [5]
Use one-click lesion segmentation and propagation algorithm to assess the treatment response.
1. Chiaradia et al, J J,Sensitivity and Reproducibility of AFD Software for HCC, VascIntervRadiol2018;29:425-431.
2. Miyayama S, et al.Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheterarterial chemoembolization. J VascIntervRadiol. 2013; 24(4):501-8.
3. Abi-jaoudeh et al , Cone Beam vs Conventional CT Navigation for Image-Guided Biopsy, J VascIntervRadio; 2016; 27: 1342–1349.
4. Ji Yung Choo, Percutaneous transthoracic needle biopsy of small (1 cm) lung nodules under C-arm cone-beam CT virtual navigation guidance; EurRadiol; 2013; 23:712–719; 23:712–719.
5. Wu et al, Cost-effectiveness of imaging tumor response criteria in hepatocellular cancer after transarterial chemoembolization. J Am Coll Radiol 2021
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.